OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Long term outcome data from the EORTC 75111-10114 ETF/BCG randomized phase II study: Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer, followed by T-DM1 after progression
Hans Wildiers, Thomas Meyskens, Sandrine Marréaud, et al.
The Breast (2022) Vol. 64, pp. 100-111
Open Access | Times Cited: 16
Hans Wildiers, Thomas Meyskens, Sandrine Marréaud, et al.
The Breast (2022) Vol. 64, pp. 100-111
Open Access | Times Cited: 16
Showing 16 citing articles:
Chemotherapeutic and targeted drugs-induced immunogenic cell death in cancer models and antitumor therapy: An update review
Jiaqi Zhai, Xi Gu, Yang Liu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 55
Jiaqi Zhai, Xi Gu, Yang Liu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 55
Incidence of antibody–drug conjugate-related fatigue in patients with breast cancer: A systematic review and meta-analysis
Hengheng Zhang, Guoshuang Shen, Ping Yang, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 196, pp. 104292-104292
Closed Access | Times Cited: 4
Hengheng Zhang, Guoshuang Shen, Ping Yang, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 196, pp. 104292-104292
Closed Access | Times Cited: 4
Antibody-Drug conjugates In elderly patients With Breast Cancer
Marta Bonotto, G Pieri, Rocco Esposto, et al.
The Breast (2025) Vol. 80, pp. 104428-104428
Open Access
Marta Bonotto, G Pieri, Rocco Esposto, et al.
The Breast (2025) Vol. 80, pp. 104428-104428
Open Access
Development of a reliable cell-based reporter gene assay to measure the bioactivity of anti-HER2 therapeutic antibodies
Xiang Zhao, Weizhu Qian, Sheng Hou, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 245, pp. 116185-116185
Closed Access | Times Cited: 2
Xiang Zhao, Weizhu Qian, Sheng Hou, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 245, pp. 116185-116185
Closed Access | Times Cited: 2
Metronomic chemotherapy in cancer treatment: new wine in an old bottle
Huailiang Wu, Han-Xing Zhou, Limin Chen, et al.
Theranostics (2024) Vol. 14, Iss. 9, pp. 3548-3564
Open Access | Times Cited: 2
Huailiang Wu, Han-Xing Zhou, Limin Chen, et al.
Theranostics (2024) Vol. 14, Iss. 9, pp. 3548-3564
Open Access | Times Cited: 2
Current Research Status of Metronomic Chemotherapy in Combination Treatment of Breast Cancer
Jiaxuan Liu, Maiyue He, Zijing Wang, et al.
Oncology Research and Treatment (2022) Vol. 45, Iss. 11, pp. 681-692
Open Access | Times Cited: 11
Jiaxuan Liu, Maiyue He, Zijing Wang, et al.
Oncology Research and Treatment (2022) Vol. 45, Iss. 11, pp. 681-692
Open Access | Times Cited: 11
Cardiac toxicity of HER-2 targeting antibody–drug conjugates: overview and clinicalimplications
Ziad Zalaquett, Maria Catherine Rita Hachem, Ahmad Assi, et al.
Future Oncology (2024), pp. 1-17
Closed Access | Times Cited: 1
Ziad Zalaquett, Maria Catherine Rita Hachem, Ahmad Assi, et al.
Future Oncology (2024), pp. 1-17
Closed Access | Times Cited: 1
Incidence of antibody–drug conjugate-related hepatotoxicity in breast cancer: a systematic review and meta-analysis
Ping Yang, Hengheng Zhang, Jinming Li, et al.
Therapeutic Advances in Drug Safety (2024) Vol. 15
Open Access | Times Cited: 1
Ping Yang, Hengheng Zhang, Jinming Li, et al.
Therapeutic Advances in Drug Safety (2024) Vol. 15
Open Access | Times Cited: 1
Real-World Experience of Metronomic Chemotherapy in Metastatic Breast Cancer: Results of a Retrospective Unicenter Study
Slavomir Krajnak, Jana Krajňáková, Katharina Anić, et al.
Breast Care (2023) Vol. 18, Iss. 2, pp. 97-105
Open Access | Times Cited: 2
Slavomir Krajnak, Jana Krajňáková, Katharina Anić, et al.
Breast Care (2023) Vol. 18, Iss. 2, pp. 97-105
Open Access | Times Cited: 2
A Comprehensive Review on the State of the Art of Breast Cancers in Italy
Domenico Iacopetta, Jessica Ceramella, Alessia Catalano, et al.
Current Medicinal Chemistry (2024) Vol. 31, Iss. 18, pp. 2486-2506
Open Access
Domenico Iacopetta, Jessica Ceramella, Alessia Catalano, et al.
Current Medicinal Chemistry (2024) Vol. 31, Iss. 18, pp. 2486-2506
Open Access
Recent Developments in Treatment of Older Patients with Breast Cancer
Julia Landin, Marcus Vetter, Ute Gick, et al.
healthbook TIMES Oncology Hematology (2024), Iss. 19
Open Access
Julia Landin, Marcus Vetter, Ute Gick, et al.
healthbook TIMES Oncology Hematology (2024), Iss. 19
Open Access
Advancements in conventional cancer therapy combined with immunotherapy
Hongxia Li, Songyan Han, Chunbo Dong, et al.
Oncology and Translational Medicine (2024) Vol. 11, Iss. 1, pp. 17-28
Open Access
Hongxia Li, Songyan Han, Chunbo Dong, et al.
Oncology and Translational Medicine (2024) Vol. 11, Iss. 1, pp. 17-28
Open Access
Metronomic chemotherapy and breast cancer: a critical evaluation of its role in the new landscape of therapeutics
Chiara Guarini, Anna Santoro, Assunta Melaccio, et al.
Expert Opinion on Drug Safety (2024), pp. 1-8
Closed Access
Chiara Guarini, Anna Santoro, Assunta Melaccio, et al.
Expert Opinion on Drug Safety (2024), pp. 1-8
Closed Access
Metronomic chemotherapy in breast cancer as a strategy to deliver more sustainable and less toxic treatments: time to debunk the myth?
Elena Battaiotto, Sasha D’Ambrosio, Dario Trapani, et al.
Clinical Breast Cancer (2024)
Closed Access
Elena Battaiotto, Sasha D’Ambrosio, Dario Trapani, et al.
Clinical Breast Cancer (2024)
Closed Access
Protein Kinase Inhibitors as a New Target for Immune System Modulation and Brain Cancer Management
Alessia Filippone, Deborah Mannino, Giovanna Casili, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15693-15693
Open Access | Times Cited: 1
Alessia Filippone, Deborah Mannino, Giovanna Casili, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15693-15693
Open Access | Times Cited: 1
Cancer-Associated Fibroblasts and Their Role in Cancer Progression
Lukáš Lacina, Pavol Szabó, I Klepácek, et al.
(2022), pp. 103-133
Closed Access | Times Cited: 1
Lukáš Lacina, Pavol Szabó, I Klepácek, et al.
(2022), pp. 103-133
Closed Access | Times Cited: 1
